4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-002658
Pres., R&D, and CMO sold 648 shares at $335.24 ($217,236)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Pres., R&D, and CMO | 2025-01-24 | Sale | −648 | $335.24 | $217,236 | 456,662 | D |
| Open-market sales · 648 sh · avg $335.24 · $217,236 | |||||||
Loading xslF345X05/wk-form4_1738015664.xml…